SCHEMBL1072526

SCHEMBL1072526

CC1(C)CCC(C)(C)c2cc(C=Cc3ccc(C(=O)O)cc3)c(Br)cc21

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 14/20 0.74
RARG P13631 14/20 0.74
RARA P10276 11/20 0.74
RXRA P19793 13/20 0.62
CYP26A1 O43174 2/20 0.54
KDM4E B2RXH2 1/20 0.54
NPC1 O15118 1/20 0.54
GMNN O75496 1/20 0.54
USP2 O75604 1/20 0.54
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
POLB P06746 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
NFKB1 P19838 1/20 0.54
CYP2C19 P33261 1/20 0.54
THPO P40225 1/20 0.54
MTOR P42345 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4709119 0.86 RARB (0.56) RARBRARGRARARXRACYP26A1
SCHEMBL4709125 0.86 RARB (0.56) RARBRARGRARARXRACYP26A1
SCHEMBL156460 0.85 RARB (1.00) RARBRARGRARARXRACYP26A1
SCHEMBL10841477 0.85 RARB (1.00) RARBRARGRARARXRACYP26A1
Hydrochloric Acid SCHEMBL4432609 0.84 RARB (0.97) RARBRARGRARARXRACYP26A1
SCHEMBL4799160 0.83 RARA (0.56) RARBRARGRARARXRACYP26A1
SCHEMBL4799144 0.83 RARA (0.56) RARBRARGRARARXRACYP26A1
SCHEMBL7213492 0.83 RARB (0.73) RARBRARGRARARXRACYP26A1
SCHEMBL1073919 0.83 RARB (0.73) RARBRARGRARARXRACYP26A1
SCHEMBL14017920 0.82 RARB (0.71) RARBRARGRARARXRACYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015059632-A1 TREATMENT OF A NEURODEGENERATIVE DISEASE OR DISORDER ACADIA PHARMACEUTICALS INC. (US) 2015-04-30 WO disclosed
EP-2766018-A2 RXR AGONISTS COMPOUNDS AND METHODS Case Western Reserve University (US) 2014-08-20 EP disclosed
WO-2013056232-A2 RXR AGONISTS COMPOUNDS AND METHODS CASE WESTERN RESERVE UNIVERSITY (US) 2013-04-18 WO disclosed
EP-2451455-A2 RXR AGONIST COMPOUNDS AND METHODS Case Western Reserve University (US) 2012-05-16 EP disclosed
WO-2011006157-A2 RXR AGONIST COMPOUNDS AND METHODS CASE WESTERN RESERVE UNIVERSITY (US) 2011-01-13 WO disclosed
WO-1995011217-A1 ISOTOPICALLY-LABELED RETINOIDS, THEIR PRODUCTION AND USE LIGAND PHARMACEUTICALS INCORPORATED (US) 1995-04-27 WO disclosed